Gene_Name	Drug_Name	Interaction_Type	Source	Gene_Categories
CD40	DACETUZUMAB	inhibitor	ChemblInteractions	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
CD40	DACETUZUMAB	antibody	TTD	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
CD40	DACETUZUMAB		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
CD40	PG-102	inhibitor	ChemblInteractions	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
CD40	PG102		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
CD40	TENELIXIMAB	partial agonist	ChemblInteractions	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
CD40	TETANUS TOXOID		NCI	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
CD40	STREPTOZOTOCIN		NCI	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
CD40	LUCATUMUMAB		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
CD40	HYDROQUINONE		NCI	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
CD40	FLUDARABINE		NCI	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
HLA-DRB1	Glatiramer Acetate	binder	DrugBank	Cell surface,druggable genome
HLA-DRB1	Lapatinib		FDA	Cell surface,druggable genome
HLA-DRB1	LYM-1		ChemblInteractions	Cell surface,druggable genome
PSORS1C2	NEVIRAPINE		PharmGKB	
C4B	Immune Globulin Human	binder	DrugBank	Druggable genome,protease,protease inhibitor
ANKK1	OLANZAPINE		PharmGKB	Druggable genome,kinase,serine threonine kinase
ANKK1	RISPERIDONE		PharmGKB	Druggable genome,kinase,serine threonine kinase
ANKK1	ARIPIPRAZOLE		PharmGKB	Druggable genome,kinase,serine threonine kinase
ANKK1	NEMONAPRIDE		PharmGKB	Druggable genome,kinase,serine threonine kinase
ANKK1	CLOZAPINE		PharmGKB	Druggable genome,kinase,serine threonine kinase
ANKK1	ETHANOL		PharmGKB	Druggable genome,kinase,serine threonine kinase
ANKK1	BUPROPION		PharmGKB	Druggable genome,kinase,serine threonine kinase
CACNA1C	Isradipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA1C	ISRADIPINE		TEND	Druggable genome,ion channel,transporter
CACNA1C	ISRADIPINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA1C	ISRADIPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	Nimodipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA1C	NIMODIPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	Nisoldipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA1C	NISOLDIPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	NISOLDIPINE	gating inhibitor	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
CACNA1C	Cinnarizine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA1C	VERAPAMIL		TEND	Druggable genome,ion channel,transporter
CACNA1C	Verapamil	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA1C	VERAPAMIL	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
CACNA1C	VERAPAMIL		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA1C	Felodipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA1C	FELODIPINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA1C	FELODIPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	Nitrendipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA1C	Nifedipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA1C	NIFEDIPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	DILTIAZEM	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
CACNA1C	MIBEFRADIL	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
CACNA1C	Mibefradil	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA1C	PB2+	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
CACNA1C	Nilvadipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA1C	Drotaverine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA1C	BEPRIDIL HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	GABAPENTIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	GABAPENTIN ENACARBIL	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	AZD1305	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	IMAGABALIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	Clevidipine		DrugBank	Druggable genome,ion channel,transporter
CACNA1C	CLEVIDIPINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA1C	CLEVIDIPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	DRONEDARONE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	AMLODIPINE MALEATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	PREGABALIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	ATAGABALIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	ELPETRIGINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	VERAPAMIL HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	DILTIAZEM MALATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	AMLODIPINE BESYLATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	NICARDIPINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	DILTIAZEM HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA1C	IBUTILIDE		TEND	Druggable genome,ion channel,transporter
CACNA1C	IBUTILIDE		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA1C	CELECOXIB		PharmGKB	Druggable genome,ion channel,transporter
CACNA1C	Dronedarone		DrugBank	Druggable genome,ion channel,transporter
CACNA1C	Magnesium Sulfate		DrugBank	Druggable genome,ion channel,transporter
CACNA1C	NICARDIPINE		TEND	Druggable genome,ion channel,transporter
CACNA1C	NICARDIPINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA1C	AMLODIPINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
CCHCR1	NEVIRAPINE		PharmGKB	
EP300	C646	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,dna repair,druggable genome,histone modification,transcription factor binding,transcription factor complex,tumor suppressor
EP300	CURCUMIN	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,dna repair,druggable genome,histone modification,transcription factor binding,transcription factor complex,tumor suppressor
EP300	EPIGALLOCATECHIN-3-GALLATE	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,dna repair,druggable genome,histone modification,transcription factor binding,transcription factor complex,tumor suppressor
EP300	GARCINOL	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,dna repair,druggable genome,histone modification,transcription factor binding,transcription factor complex,tumor suppressor
EP300	PLUMBAGIN	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,dna repair,druggable genome,histone modification,transcription factor binding,transcription factor complex,tumor suppressor
C4A	Immune Globulin Human	binder	DrugBank	Druggable genome,protease,protease inhibitor
NOTCH4	PF-03084014	inhibitor	MyCancerGenome	Cell surface,clinically actionable,druggable genome
NOTCH4	REGN421	antibody	MyCancerGenome	Cell surface,clinically actionable,druggable genome
MMP16	Marimastat	inhibitor	DrugBank	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
MMP16	ILOMASTAT	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
MMP16	SL422	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
MMP16	Batimastat		DrugBank	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
DRD2	LURASIDONE HYDROCHLORIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LURASIDONE HYDROCHLORIDE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Olanzapine	agonist,antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	OLANZAPINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	OLANZAPINE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	OLANZAPINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	OLANZAPINE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	OLANZAPINE		PharmGKB	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	OLANZAPINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Seridopidine	modulator	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PRIDOPIDINE	modulator	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PRIDOPIDINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUPHENAZINE ENANTHATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BENZQUINAMIDE HYDROCHLORIDE	modulator	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SARIZOTAN HYDROCHLORIDE	partial agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LOXAPINE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Loxapine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LOXAPINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LOXAPINE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LOXAPINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LOXAPINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ZIPRASIDONE MESYLATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	AMOXAPINE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Amoxapine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LOXAPINE HYDROCHLORIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROPINIROLE HYDROCHLORIDE	agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LEVOMEPROMAZINE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Methotrimeprazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROCHLORPERAZINE MALEATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUPHENAZINE DECANOATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DAPOTUM D	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DOMPERIDONE MALEATE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Domperidone	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DOMPERIDONE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DOMPERIDONE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DOMPERIDONE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Amphetamine	binder	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Cabergoline	agonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CABERGOLINE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CABERGOLINE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CABERGOLINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CABERGOLINE	agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CABERGOLINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Ropinirole	agonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROPINIROLE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROPINIROLE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROPINIROLE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROPINIROL		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROPINIROLE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CLOZAPINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CLOZAPINE		NCI	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CLOZAPINE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Clozapine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CLOZAPINE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CLOZAPINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CLOZAPINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Mirtazapine	binder	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Thiethylperazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	THIETHYLPERAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	THIETHYLPERAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	REMOXIPRIDE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Remoxipride	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	REMOXIPRIDE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	REMOXIPRIDE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Promazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROMAZINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROMAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROMAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Droperidol	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DROPERIDOL	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DROPERIDOL		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DROPERIDOL		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Triflupromazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	TRIFLUPROMAZINE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	TRIFLUPROMAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	TRIFLUPROMAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Lisuride	agonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LISURIDE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LISURIDE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LISURIDE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Ergotamine	agonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	APOMORPHINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Apomorphine	agonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	APOMORPHINE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	APOMORPHINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Risperidone	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	RISPERIDONE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	RISPERIDONE CONSTA	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	RISPERIDONE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	RISPERIDONE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	RISPERDAL		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	RISPERIDONE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	RISPERIDONE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Propiomazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROPIOMAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROPIOMAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Minaprine	agonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MINAPRINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MINAPRINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Perphenazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PERPHENAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PERPHENAZINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PERPHENAZINE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PERPHENAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PERPHENAZINE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUPENTIXOL	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Flupentixol	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUPENTHIXOL	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Amantadine	agonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MESORIDAZINE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Mesoridazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MESORIDAZINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MESORIDAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MESORIDAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CARPHENAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Carphenazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CARPHENAZINE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CARPHENAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Ergoloid mesylate	agonist,antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ERGOLOID MESYLATES	agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ACETOPHENAZINE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ACETOPHENAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Acetophenazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ACETOPHENAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Pimozide	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PIMOZIDE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PIMOZIDE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PIMOZIDE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PIMOZIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PIMOZIDE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Levodopa	agonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LEVODOPA		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LEVODOPA		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ARIPIPRAZOLE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ARIPIPRAZOLE	partial agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Aripiprazole	partial agonist,antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ARIPIPRAZOLE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ARIPIPRAZOLE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ARIPIPRAZOLE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BENZQUINAMIDE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	COMPOUND 3 [PMID: 23134120]	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROTIGOTINE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROTIGOTINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Rotigotine	agonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROTIGOTINE	agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	N-0923	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROTIGOTINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	VILAZODONE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	UNC0006	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	UNC9975	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	UNC9994	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	7-OH-DPAT	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BROMOCRIPTINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BROMOCRIPTINE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BROMOCRIPTINE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BROMOCRIPTINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DOPAMINE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DOPAMINE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PD 128907	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PERGOLIDE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PERGOLIDE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PERGOLIDE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PERGOLIDE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PRAMIPEXOLE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PRAMIPEXOLE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PRAMIPEXOLE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PRAMIPEXOLE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	QUINELORANE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	QUINPIROLE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SUMANIROLE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SUMANIROLE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	OPC-34712		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BREXPIPRAZOLE	partial agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BREXPIPRAZOLE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Brexpiprazole	partial agonist,agonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CARIPRAZINE	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Cariprazine	partial agonist,agonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CARIPRAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PIRIBEDIL	agonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROXINDOLE	agonist,antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	TERGURIDE	agonist,antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Amisulpride	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	AMISULPRIDE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	AMISULPRIDE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	AMISULPRIDE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	AMISULPRIDE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ASENAPINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ASENAPINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ASENAPINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BENPERIDOL	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BLONANSERIN	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BLONANSERIN	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	(+)-BUTACLAMOL	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CHLORPROMAZINE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CHLORPROMAZINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CHLORPROMAZINE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CHLORPROMAZINE		PharmGKB	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ETICLOPRIDE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUPHENAZINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUPHENAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUPHENAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	HALOPERIDOL	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	HALOPERIDOL		NCI	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	HALOPERIDOL	inverse agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	HALOPERIDOL		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	HALOPERIDOL		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	HALOPERIDOL	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	TRANS-FLUPENTHIXOL	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	NAFADOTRIDE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PEROSPIRONE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Pipotiazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PIPOTIAZINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROCHLORPERAZINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROCHLORPERAZINE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROCHLORPERAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROCHLORPERAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	QUETIAPINE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	QUETIAPINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PD-172760	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	QUETIAPINE SR	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	QUETIAPINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	QUETIAPINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LAMECTACIN	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	RACLOPRIDE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	(+)-S-14297	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	(+)-SCH-23390	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SERTINDOLE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SERTINDOLE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Sertindole	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SERTINDOLE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SERTINDOLE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	(-)-STEPHOLIDINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	(-)-SULPIRIDE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SULPIRIDE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SULPIRIDE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SULPIRIDE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SULPIRIDE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	(+)-SULPIRIDE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	[3H]NEMONAPRIDE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	TRIFLUOPERAZINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	TRIFLUOPERAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	TRIFLUOPERAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ZIPRASIDONE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ZIPRASIDONE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ZIPRASIDONE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ZOTEPINE	antagonist	GuideToPharmacologyInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CHLORPROTHIXENE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Chlorprothixene	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CHLORPROTHIXENE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CHLORPROTHIXENE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CHLORPROTHIXENE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Paliperidone	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PALIPERIDONE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PALIPERIDONE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PALIPERIDONE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PALIPERIDONE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Yohimbine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Alizapride	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Acepromazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Thioproperazine	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Thiothixene	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	THIOTHIXENE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Zuclopenthixol	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ZUCLOPENTHIXOL	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ZUCLOPENTHIXOL		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ZUCLOPENTHIXOL		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUSPIRILENE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Fluspirilene	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUSPIRILENE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUSPIRILENE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Tetrabenazine	inhibitor	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Iloperidone	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ILOPERIDONE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ILOPERIDONE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ILOPERIDONE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ILOPERIDONE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Mianserin	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LURASIDONE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Lurasidone	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LURASIDONE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Bromopride	antagonist	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Tiapride	blocker	DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SLV-310	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BROMOCRIPTINE MESYLATE	agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CHLORPROMAZINE HYDROCHLORIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	OLANZAPINE PAMOATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PRAMIPEXOLE DIHYDROCHLORIDE	agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CARPHENAZINE MALEATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROMAZINE HYDROCHLORIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	HALOPERIDOL DECANOATE	inverse agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	THIORIDAZINE HYDROCHLORIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	THIORIDAZINE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	THIORIDAZINE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	THIORIDAZINE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	APOMORPHINE HYDROCHLORIDE	agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	QUETIAPINE FUMARATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ZIPRASIDONE HYDROCHLORIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ARIPIPRAZOLE LAUROXIL	partial agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Ordopidine	modulator	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SB-773812	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LOXAPINE SUCCINATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	HALOPERIDOL LACTATE	inverse agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	TRIFLUOPERAZINE HYDROCHLORIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PROCHLORPERAZINE EDISYLATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PARDOPRUNOX	partial agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PARDOPRUNOX	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PARDOPRUNOX		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BIFEPRUNOX	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Bifeprunox		DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BIFEPRUNOX	partial agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BIFEPRUNOX		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	TRIFLUPROMAZINE HYDROCHLORIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ASENAPINE MALEATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PALIPERIDONE PALMITATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MESORIDAZINE BESYLATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	METOCLOPRAMIDE HYDROCHLORIDE HYDRATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MOLINDONE HYDROCHLORIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	THIOTHIXENE HYDROCHLORIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	TRIMIPRAMINE MALEATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ROTIGOTINE PATCH	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	QUINAGOLIDE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	QUINAGOLIDE HYDROCHLORIDE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	METOCLOPRAMIDE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	METOCLOPRAMIDE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	METOCLOPRAMIDE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DIHYDROERGOTOXINE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	METHAMFETAMINE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MOLINDONE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MOLINDONE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MOLINDONE	binder	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DEXAMFETAMINE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PD-157695	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ORG-23366	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	GMC-283	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	NOMIFENSINE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ABAPERIDONE HYDROCHLORIDE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PD-158771	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	1192U90	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SLV-313	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ITI-007	partial agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ITI-007		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CARIPRAZINE HYDROCHLORIDE	modulator	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	THIETHYLPERAZINE MALATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SDZ-HDC-912	binder	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	HMR-2934	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	PERGOLIDE MESYLATE	agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ACETOPHENAZINE MALEATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	NEMONAPRIDE		PharmGKB	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	NEMONAPRIDE	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	(S)-AMISULPRIDE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ASENAPINE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SIBENADET	agonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	OCAPERIDONE	antagonist	TTD	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUPHENAZINE HYDROCHLORIDE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	APLINDORE FUMARATE	partial agonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	THIETHYLPERAZINE MALEATE	antagonist	ChemblInteractions	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	SLV 308		DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MELEVODOPA		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Bicifadine		DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Itopride		DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ITOPRIDE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ACP-104		DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ACP-104		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Rolicyclidine		DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BIM23A760		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ETILEVODOPA		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BL-1020		DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	LITHIUM		NCI	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	ETHANOL		NCI	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	MORPHINE		NCI	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BUPROPION		PharmGKB	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	JNJ-37822681		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Pimavanserin		DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Brasofensine		DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	APLINDORE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	CAFFEINE		PharmGKB	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUPENTHIXOL		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	FLUPENTHIXOL		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Aniracetam		DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BUSPIRONE		TEND	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BUSPIRONE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	DEXPRAMIPEXOLE		TdgClinicalTrial	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	BROMPERIDOL		PharmGKB	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
DRD2	Cinnarizine		DrugBank	Abc transporter,cell surface,dna repair,drug metabolism,drug resistance,druggable genome,external side of plasma membrane,g protein coupled receptor,growth factor,histone modification,hormone activity,ion channel,kinase,lipid kinase,neutral zinc metallopeptidase,nuclear hormone receptor,phospholipase,protease,protease inhibitor,protein phosphatase,rna directed dna polymerase,serine threonine kinase,transcription factor binding,transcription factor complex,transporter,tumor suppressor,tyrosine kinase
MAPT	Paclitaxel		DrugBank	Druggable genome,kinase,protease
MAPT	Docetaxel		DrugBank	Druggable genome,kinase,protease
HLA-A	CARBAMAZEPINE		PharmGKB	Cell surface,druggable genome
HLA-A	Carbamazepine		FDA	Cell surface,druggable genome
HLA-A	3-Indolebutyric Acid		DrugBank	Cell surface,druggable genome
CRHR1	SAUVAGINE	agonist	GuideToPharmacologyInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	UROCORTIN 1	agonist	GuideToPharmacologyInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	UROCORTIN 1	agonist	GuideToPharmacologyInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	UROCORTIN 2	agonist	GuideToPharmacologyInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	ANTALARMIN	antagonist	GuideToPharmacologyInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	DMP696	antagonist	GuideToPharmacologyInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	SSR125543A	antagonist	GuideToPharmacologyInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	SSR125543	antagonist	TTD	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	SSR125543	antagonist	ChemblInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	CRF-1 ANTAGONIST	antagonist	TTD	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	PEXACERFONT	antagonist	TTD	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	PEXACERFONT	antagonist	ChemblInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	GW876008	antagonist	TTD	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	EMICERFONT	antagonist	ChemblInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	VERUCERFONT	antagonist	ChemblInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	GSK561679	antagonist	TTD	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	CP-316,311	antagonist	TTD	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	ONO-2333Ms	antagonist	ChemblInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
CRHR1	FLUOXETINE		PharmGKB	Druggable genome,g protein coupled receptor,ion channel,transporter
POU5F1	ETHANOL		NCI	
FLOT1	CARBAMAZEPINE		PharmGKB	
AMT	Tetrahydrofolic acid	cofactor	DrugBank	
AMT	NADH		DrugBank	
MTHFD1	Tetrahydrofolic acid	cofactor	DrugBank	
MTHFD1	NADH		DrugBank	
MTHFD1	2'-Monophosphoadenosine 5'-Diphosphoribose		DrugBank	
GPX1	Glutathione		DrugBank	Druggable genome,protease,protease inhibitor
GPX1	Glutathione	cofactor	DrugBank	Druggable genome,protease,protease inhibitor
XPNPEP3	TOSEDOSTAT	inhibitor	ChemblInteractions	Druggable genome,neutral zinc metallopeptidase,protease
CRYZ	Dicoumarol	inhibitor	DrugBank	Druggable genome
CRYZ	2'-Monophosphoadenosine 5'-Diphosphoribose		DrugBank	Druggable genome
NAGA	Glycerol		DrugBank	Druggable genome
BAG6	CARBAMAZEPINE		PharmGKB	
PRRC2A	CARBAMAZEPINE		PharmGKB	
CYP2D6	GLUTETHIMIDE	inducer	TTD	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Codeine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	CODEINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	FLUPENTHIXOL		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	SPARTEINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Fluvoxamine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	ALBUMIN		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	HYDROXYCHLOROQUINE		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	PROPRANOLOL		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Propranolol		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	CLOZAPINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Clozapine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Paroxetine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	PAROXETINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	ACETAMINOPHEN		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Arformoterol		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	ATOMOXETINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Atomoxetine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	GINKGO BILOBA		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	HYPERICIN		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	CHLORPROMAZINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	DOXEPIN		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Doxepin		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Valbenazine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Palonosetron		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	RISPERIDONE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Risperidone		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	MIANSERIN		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Fesoterodine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Nefazodone		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Darifenacin		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	GALANTAMINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Galantamine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	PERPHENAZINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Perphenazine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	DESIPRAMINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Desipramine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Iloperidone		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	ILOPERIDONE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	VENLAFAXINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Venlafaxine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	ERLOTINIB		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Metoprolol		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Nebivolol		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	GEFITINIB		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Thioridazine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	DEBRISOQUINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Duloxetine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	YOHIMBINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	CELECOXIB		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	CARVEDILOL		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Carvedilol		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Tramadol		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Dextromethorphan		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	DEXTROMETHORPHAN		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	FLUOXETINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Fluoxetine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	MIRTAZAPINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Escitalopram		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	OLANZAPINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	PIMOZIDE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Pimozide		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	TACROLIMUS		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Flibanserin		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	TOLTERODINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Tolterodine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	GARLIC		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	MODAFINIL		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	MODAFINIL		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Modafinil		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	METHYLPHENIDATE		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	PERHEXILINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Imipramine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Trimipramine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	TRIMIPRAMINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Citalopram		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	ARIPIPRAZOLE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Aripiprazole		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	TERBINAFINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	AMPHETAMINE		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	TETRABENAZINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Tetrabenazine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	STREPTOZOTOCIN		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Protriptyline		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	PROTRIPTYLINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Eliglustat		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Propafenone		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Paliperidone		DrugBank	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	NORTRIPTYLINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Nortriptyline		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	TIOTROPIUM		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	DESLORATADINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	VORICONAZOLE		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	FLECAINIDE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	MEXILETINE		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	MEXILETINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Ondansetron		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Clomipramine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	CLOMIPRAMINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	MAPROTILINE		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	ACTH		NCI	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Vortioxetine		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Cevimeline		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Rucaparib		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	ZUCLOPENTHIXOL		PharmGKB	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Quinine Sulfate		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Amitriptyline		FDA	Cytochrome p450,drug metabolism,druggable genome
CYP2D6	Brexpiprazole		FDA	Cytochrome p450,drug metabolism,druggable genome
AS3MT	ARSENITE		PharmGKB	
CYP21A2	Ketoconazole		DrugBank	Cytochrome p450,druggable genome
CYP2D7	CODEINE		PharmGKB	Drug metabolism,drug resistance
CYP2D7	Aripiprazole Lauroxil		FDA	Drug metabolism,drug resistance
LOXL2	SIMTUZUMAB	inhibitor	GuideToPharmacologyInteractions	Druggable genome,histone modification
LOXL2	Simtuzumab	inhibitor	ChemblInteractions	Druggable genome,histone modification
HLA-DRA	NIVOLUMAB		CIViC	Cell surface,druggable genome
HLA-DRA	PEMBROLIZUMAB		CIViC	Cell surface,druggable genome
HLA-DRA	ATEZOLIZUMAB		CIViC	Cell surface,druggable genome
HLA-DQB1	CLAVULANATE		PharmGKB	
HLA-DQB1	AMOXICILLIN		PharmGKB	
HLA-DQA1	INTERFERON BETA-1B		PharmGKB	
HLA-DQA1	INTERFERON BETA-1A		PharmGKB	
HLA-DQA1	Lapatinib		FDA	
NDUFS3	METFORMIN HYDROCHLORIDE	inhibitor	ChemblInteractions	Druggable genome
NDUFS3	ME-344	inhibitor	ChemblInteractions	Druggable genome
NDUFS3	NV-128	inhibitor	ChemblInteractions	Druggable genome
NDUFS3	NADH		DrugBank	Druggable genome
TMCO6	FLUTICASONE PROPIONATE		PharmGKB	Transporter
DALRD3	MYCOPHENOLIC ACID		PharmGKB	
P4HTM	ROXADUSTAT	inhibitor	ChemblInteractions	Druggable genome
P4HTM	DAPRODUSTAT	inhibitor	ChemblInteractions	Druggable genome
P4HTM	Vitamin C		DrugBank	Druggable genome
NT5C2	Ribavirin	inducer	DrugBank	Drug metabolism,kinase
NT5C2	6-THIOGUANINE		CIViC	Drug metabolism,kinase
NT5C2	6-MERCAPTOPURINE		CIViC	Drug metabolism,kinase
NT5C2	Adenosine triphosphate		DrugBank	Drug metabolism,kinase
ARL3	Guanosine-5'-Diphosphate		DrugBank	
MST1R	MGCD265	inhibitor	TALC	Cell surface,druggable genome,kinase,serine threonine kinase,tyrosine kinase
MST1R	MGCD265		TdgClinicalTrial	Cell surface,druggable genome,kinase,serine threonine kinase,tyrosine kinase
MST1R	MGCD-265	inhibitor	ChemblInteractions	Cell surface,druggable genome,kinase,serine threonine kinase,tyrosine kinase
MST1R	BMS-777607	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,kinase,serine threonine kinase,tyrosine kinase
MST1R	MK-2461	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,kinase,serine threonine kinase,tyrosine kinase
MST1R	FORETINIB	inhibitor	TALC	Cell surface,druggable genome,kinase,serine threonine kinase,tyrosine kinase
MST1R	MK-8033	inhibitor	ChemblInteractions	Cell surface,druggable genome,kinase,serine threonine kinase,tyrosine kinase
PEBP1	DHT		NCI	Druggable genome,protease,protease inhibitor
PEBP1	FLUTAMIDE		NCI	Druggable genome,protease,protease inhibitor
HARS	L-Histidine		DrugBank	
CFB	4-Guanidinobenzoic Acid		DrugBank	Druggable genome,protease
KYAT3	Pyridoxal Phosphate	cofactor	DrugBank	
KYAT3	L-Glutamic Acid		DrugBank	
MADD	VERAPAMIL		PharmGKB	Kinase,serine threonine kinase,tumor suppressor
F2	Lepirudin	inhibitor	DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	LEPIRUDIN	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	LEPIRUDIN		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	LEPIRUDIN	inhibitor	TTD	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	LEPIRUDIN		TEND	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	LEPIRUDIN	inhibitor	ChemblInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	BIVALIRUDIN		TEND	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Bivalirudin	inhibitor	DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	BIVALIRUDIN	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	BIVALIRUDIN	inhibitor	ChemblInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	BIVALIRUDIN		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	BIVALIRUDIN	inhibitor	TTD	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Menadione	activator	DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	MENADIONE		TEND	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Argatroban	inhibitor	DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	ARGATROBAN	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	ARGATROBAN	inhibitor	ChemblInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	ARGATROBAN		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	DABIGATRAN	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	DABIGATRAN	inhibitor	ChemblInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	DABIGATRAN		TEND	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	DABIGATRAN		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	DABIGATRAN	inhibitor	TTD	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	DESIRUDIN	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	DESIRUDIN	inhibitor	ChemblInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	DUP-714	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	MELAGATRAN	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	XIMELEGATRAN	inhibitor	TTD	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	XIMELAGATRAN	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Ximelagatran	inhibitor	DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	XIMELAGATRAN		TEND	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	XIMELAGATRAN	inhibitor	TTD	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	XIMELAGATRAN		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Suramin	inhibitor	DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Thrombomodulin Alfa	inhibitor	DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	C1 Esterase Inhibitor (Human)	inhibitor	DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	C1 Esterase Inhibitor (Recombinant)	inhibitor	DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	DERMOLASTIN	inhibitor	TTD	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	DERMOLASTIN		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	AZD-0837		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	AZD0837	inhibitor	TTD	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	DABIGATRAN ETEXILATE MESYLATE	inhibitor	ChemblInteractions	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	3-(4-HYDROXY-PHENYL)PYRUVIC ACID		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	ENOXAPARIN		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Hemi-Babim		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	D-phenylalanyl-N-benzyl-L-prolinamide		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Proflavine		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	CRA_8696		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Tamoxifen		FDA	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	2-NAPHTHALENESULFONIC ACID		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	BENZOTHIAZOLE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	HEPARIN		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	HEPARIN		TEND	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Coagulation Factor IX (Recombinant)		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	AC-(D)PHE-PRO-BOROLYS-OH		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	methyl L-phenylalaninate		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Gamma-Carboxy-Glutamic Acid		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	Drotrecogin alfa		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	4-Iodobenzo[B]Thiophene-2-Carboxamidine		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
F2	N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide		DrugBank	Cell surface,druggable genome,external side of plasma membrane,growth factor,kinase,lipid kinase,protease
PBRM1	Everolimus		CGI	Clinically actionable
RTN4	OZANEZUMAB	antibody	GuideToPharmacologyInteractions	Druggable genome
RTN4	OZANEZUMAB	inhibitor	ChemblInteractions	Druggable genome
NDUFA6	NV-128	inhibitor	ChemblInteractions	
NDUFA6	ME-344	inhibitor	ChemblInteractions	
NDUFA6	METFORMIN HYDROCHLORIDE	inhibitor	ChemblInteractions	
NDUFA6	NADH		DrugBank	
FDFT1	TAK-475		DrugBank	Druggable genome
FDFT1	LAPAQUISTAT ACETATE	inhibitor	ChemblInteractions	Druggable genome
FDFT1	LAPAQUISTAT ACETATE	inhibitor	TTD	Druggable genome
FDFT1	LOVASTATIN		NCI	Druggable genome
MMAB	Hydroxocobalamin	other	DrugBank	
NMT1	(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone		DrugBank	Druggable genome
BRD2	RVX 208	antagonist	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
BRD2	BIC1	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
BRD2	COMPOUND 4D [PMID: 21851057]	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
BRD2	GW841819X	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
BRD2	I-BET151	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
BRD2	I-BET-762	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
BRD2	LY 294002	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
BRD2	PMA		NCI	Druggable genome,kinase,serine threonine kinase
PANX1	Probenecid	antagonist	DrugBank	Ion channel,transporter
PANX1	CARBENOXOLONE	inhibitor	GuideToPharmacologyInteractions	Ion channel,transporter
PANX1	FLUFENAMIC ACID	inhibitor	GuideToPharmacologyInteractions	Ion channel,transporter
KCNQ5	FLINDOKALNER	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
KCNQ5	FLINDOKALNER	activator	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ5	Ezogabine		DrugBank	Druggable genome,ion channel,transporter
KCNQ5	RETIGABINE	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
KCNQ5	RETIGABINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
KCNQ5	EZOGABINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ5	(S)-N-[1-(3-MORPHOLIN-4-YL-PHENYL)-ETHYL]-3-PHENYL-ACRYLAMIDE	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
KCNQ5	LINOPIRDINE	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
KCNQ5	XE991	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
KCNQ5	DALFAMPRIDINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ5	GUANIDINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ5	TEDISAMIL	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ5	NERISPIRDINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ5	CELECOXIB		PharmGKB	Druggable genome,ion channel,transporter
PSMB9	Carfilzomib	inhibitor	DrugBank	Druggable genome,protease,tumor suppressor
PSMB9	CARFILZOMIB	inhibitor	MyCancerGenome	Druggable genome,protease,tumor suppressor
PSMB9	CARFILZOMIB	inhibitor	ChemblInteractions	Druggable genome,protease,tumor suppressor
PSMB9	BORTEZOMIB	inhibitor	MyCancerGenome	Druggable genome,protease,tumor suppressor
PSMB9	BORTEZOMIB	inhibitor	ChemblInteractions	Druggable genome,protease,tumor suppressor
PSMB9	IXAZOMIB CITRATE	inhibitor	ChemblInteractions	Druggable genome,protease,tumor suppressor
PSMB9	MARIZOMIB	inhibitor	ChemblInteractions	Druggable genome,protease,tumor suppressor
PSMB9	OPROZOMIB	inhibitor	ChemblInteractions	Druggable genome,protease,tumor suppressor
GPI	Erythose-4-Phosphate		DrugBank	Druggable genome,growth factor,protease
GPI	5-Phospho-D-Arabinohydroxamic Acid		DrugBank	Druggable genome,growth factor,protease
GPI	6-Phosphogluconic Acid		DrugBank	Druggable genome,growth factor,protease
GPI	D-glucitol 6-phosphate		DrugBank	Druggable genome,growth factor,protease
GPI	Glucose-6-Phosphate		DrugBank	Druggable genome,growth factor,protease
GPI	alpha-D-glucose 6-phosphate		DrugBank	Druggable genome,growth factor,protease
GPI	6-AN		NCI	Druggable genome,growth factor,protease
MST1	RETINOIC ACID		NCI	Druggable genome,kinase,protease,serine threonine kinase
XRCC3	FLUOROURACIL		PharmGKB	Dna repair,tumor suppressor
XRCC3	DOCETAXEL		PharmGKB	Dna repair,tumor suppressor
XRCC3	CISPLATIN		PharmGKB	Dna repair,tumor suppressor
HLA-DRB5	1D09C3		TdgClinicalTrial	Druggable genome
ACO2	Tricarballylic Acid		DrugBank	
ACO2	Isocitric Acid		DrugBank	
AKR1C3	4-Androstenedione	inducer	DrugBank	Druggable genome
AKR1C3	TOLFENAMIC ACID	inhibitor	GuideToPharmacologyInteractions	Druggable genome
AKR1C3	Bimatoprost		DrugBank	Druggable genome
AKR1C3	Rutin		DrugBank	Druggable genome
AKR1C3	3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN		DrugBank	Druggable genome
AKR1C3	Flufenamic Acid		DrugBank	Druggable genome
AKR1C3	TESTOSTERONE		NCI	Druggable genome
AKR1C3	(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid		DrugBank	Druggable genome
AKR1C3	2'-Monophosphoadenosine 5'-Diphosphoribose		DrugBank	Druggable genome
AKR1C3	NADH		DrugBank	Druggable genome
ESR2	Diethylstilbestrol	agonist	DrugBank	Druggable genome,nuclear hormone receptor
ESR2	Tamoxifen	agonist,antagonist	DrugBank	Druggable genome,nuclear hormone receptor
ESR2	TAMOXIFEN		PharmGKB	Druggable genome,nuclear hormone receptor
ESR2	TAMOXIFEN		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	TAMOXIFEN		TEND	Druggable genome,nuclear hormone receptor
ESR2	Trilostane	allosteric modulator	DrugBank	Druggable genome,nuclear hormone receptor
ESR2	Prasterone	activator	DrugBank	Druggable genome,nuclear hormone receptor
ESR2	5-Alpha-Androstane-3-Beta,17beta-Diol	agonist	DrugBank	Druggable genome,nuclear hormone receptor
ESR2	Estriol	agonist	DrugBank	Druggable genome,nuclear hormone receptor
ESR2	Estrone sulfate	agonist	DrugBank	Druggable genome,nuclear hormone receptor
ESR2	FULVESTRANT	antagonist	TALC	Druggable genome,nuclear hormone receptor
ESR2	FULVESTRANT		PharmGKB	Druggable genome,nuclear hormone receptor
ESR2	FULVESTRANT	antagonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	DIETHYLSTILBESTROL DIPHOSPHATE	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	BAZEDOXIFENE ACETATE	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	FISPEMIFENE		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	FISPEMIFENE	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	LY2245461	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	IDOXIFENE	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	MK-6913	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	MK-6913		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	PRINABEREL	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	ERTEBEREL	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	AUS-131		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	EQUOL	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	CR 1447	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	DROLOXIFENE	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	ACOLBIFENE	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	CHLOROTRIANISENE	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	RALOXIFENE HYDROCHLORIDE	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	ESTROGENS, ESTERIFIED	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	ESTROGENS, CONJUGATED SYNTHETIC A	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	ESTROGENS, CONJUGATED	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	OSPEMIFENE		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	OSPEMIFENE	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	QUINESTROL	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	TOREMIFENE CITRATE	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	CHF 4227		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	CHF 4227		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	CHF4227	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	MF101		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	MF101		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	MF101	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	SYNTHETIC CONJUGATED ESTROGENS, B	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	AFIMOXIFENE	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	ESTRAMUSTINE PHOSPHATE SODIUM	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESR2	2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	TAS-108		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	EXEMESTANE		PharmGKB	Druggable genome,nuclear hormone receptor
ESR2	(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	TOREMIFENE		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	Genistein		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	HYDROXYTAMOXIFEN		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	RALOXIFENE		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	RALOXIFENE		TEND	Druggable genome,nuclear hormone receptor
ESR2	Estramustine		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	A-007		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	ESTROGEN		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	Lasofoxifene		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	ESTRADIOL		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	ESTRADIOL		TEND	Druggable genome,nuclear hormone receptor
ESR2	17-BETA ESTRADIOL		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	RALOXIFEN		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	BAZEDOXIFENE		TdgClinicalTrial	Druggable genome,nuclear hormone receptor
ESR2	ALENDRONATE		PharmGKB	Druggable genome,nuclear hormone receptor
ESR2	[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE		DrugBank	Druggable genome,nuclear hormone receptor
ESR2	3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL		DrugBank	Druggable genome,nuclear hormone receptor
HCP5	ABACAVIR		PharmGKB	
HCP5	FLUCLOXACILLIN		PharmGKB	
HLA-B	Pazopanib		FDA	Cell surface,druggable genome
HLA-B	ABACAVIR		PharmGKB	Cell surface,druggable genome
HLA-B	Abacavir		FDA	Cell surface,druggable genome
HLA-B	CARBAMAZEPINE		NCI	Cell surface,druggable genome
HLA-B	CARBAMAZEPINE		PharmGKB	Cell surface,druggable genome
HLA-B	Carbamazepine		FDA	Cell surface,druggable genome
HLA-B	Oxcarbazepine		FDA	Cell surface,druggable genome
HLA-B	Phenytoin		FDA	Cell surface,druggable genome
HLA-B	THALIDOMIDE		NCI	Cell surface,druggable genome
NSF	1-Ethyl-Pyrrolidine-2,5-Dione		DrugBank	
ACP2	ATENOLOL		PharmGKB	Druggable genome
ACP2	VERAPAMIL		PharmGKB	Druggable genome
CYP2C19	Flibanserin		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Doxepin		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	CARBAMAZEPINE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	CLOZAPINE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Ethinyl Estradiol		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	ETHINYL ESTRADIOL		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Lacosamide		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Ticagrelor		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	TOPIRAMATE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	PRIMIDONE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	CLOMIPRAMINE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Esomeprazole		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	CHLORAMPHENICOL		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	MEPHENYTOIN		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	HEXOBARBITAL		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	MOCLOBEMIDE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	FLUOXETINE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Escitalopram		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	KETOCONAZOLE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	TOLBUTAMIDE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	PROGUANIL		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	DIAZEPAM		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Diazepam		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Dexlansoprazole		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	PREDNISONE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Phenytoin		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Pantoprazole		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	CIMETIDINE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	MODAFINIL		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	PROBENECID		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	PROGESTERONE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	INDOMETHACIN		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Prasugrel		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	PRASUGREL		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Omeprazole		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Isoniazid		DrugBank	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	METHYLPHENOBARBITAL		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Clopidogrel		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	PHENOBARBITAL		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Drospirenone		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	DROSPIRENONE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	PROPRANOLOL		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	ANTIBIOTICS		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	VALPROIC ACID		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	OXCARBAZEPINE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Brivaracetam		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	FELBAMATE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	CARISOPRODOL		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Carisoprodol		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Rabeprazole		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	TENIPOSIDE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Citalopram		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	LANSOPRAZOLE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Lansoprazole		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	NEVIRAPINE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	CYCLOPHOSPHAMIDE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Clobazam		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	CLOBAZAM		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	VORICONAZOLE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP2C19	Voriconazole		FDA	Cytochrome p450,drug metabolism,drug resistance,druggable genome
PCCB	Biotin		DrugBank	Druggable genome
PCCB	L-Valine		DrugBank	Druggable genome
PSMC3	OPROZOMIB	inhibitor	ChemblInteractions	Transcription factor binding,tumor suppressor
PSMC3	BORTEZOMIB	inhibitor	ChemblInteractions	Transcription factor binding,tumor suppressor
PSMC3	BORTEZOMIB	inhibitor	MyCancerGenome	Transcription factor binding,tumor suppressor
PSMC3	CARFILZOMIB	inhibitor	MyCancerGenome	Transcription factor binding,tumor suppressor
PSMC3	CARFILZOMIB	inhibitor	ChemblInteractions	Transcription factor binding,tumor suppressor
PSMC3	IXAZOMIB CITRATE	inhibitor	ChemblInteractions	Transcription factor binding,tumor suppressor
RHOA	Guanosine-5'-Diphosphate		DrugBank	Cell surface,clinically actionable,kinase,serine threonine kinase,tumor suppressor
ITPR3	CA2+	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
ITPR3	IP3	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
ITPR3	DECAVANADATE	antagonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
MAPKAPK3	COMPOUND 16 [PMID: 17480064]	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
MAPKAPK3	2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPKAPK3	2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE		DrugBank	Druggable genome,kinase,serine threonine kinase
FHIT	Fructose		DrugBank	
FHIT	TRICHOSTATIN A		NCI	
NDUFA2	METFORMIN HYDROCHLORIDE	inhibitor	ChemblInteractions	
NDUFA2	ME-344	inhibitor	ChemblInteractions	
NDUFA2	NV-128	inhibitor	ChemblInteractions	
NDUFA2	NADH		DrugBank	
UNG	3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid		DrugBank	Dna repair
UNG	4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID		DrugBank	Dna repair
CSNK1G1	COMPOUND 33 [PMID: 19364658]	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
CSNK1G1	2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE		DrugBank	Druggable genome,kinase,serine threonine kinase
TAOK3	COMPOUND 89S [PMID: 19115845]	inhibitor	GuideToPharmacologyInteractions	Dna repair,druggable genome,kinase,serine threonine kinase,tumor suppressor,tyrosine kinase
LINGO1	OPICINUMAB	inhibitor	ChemblInteractions	Druggable genome
LINGO1	OPICINUMAB	antibody	GuideToPharmacologyInteractions	Druggable genome
ACADS	Flavin adenine dinucleotide		DrugBank	
ACADS	NADH		DrugBank	
YEATS4	HYDROCHLOROTHIAZIDE		PharmGKB	Histone modification
AKR1C2	Ursodeoxycholic acid	inducer	DrugBank	Druggable genome
AKR1C2	URSODEOXYCHOLIC ACID		TdgClinicalTrial	Druggable genome
AKR1C2	NADH		DrugBank	Druggable genome
AKR1C2	2'-Monophosphoadenosine 5'-Diphosphoribose		DrugBank	Druggable genome
AKR1C2	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE		DrugBank	Druggable genome
TLR4	ERITORAN TETRASODIUM	antagonist	ChemblInteractions	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	RESATORVID	antagonist	TTD	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	RESATORVID	antagonist	GuideToPharmacologyInteractions	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	SAQUINAVIR		NCI	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	ETHANOL		NCI	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	Lauric Acid		DrugBank	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	MYRISTIC ACID		DrugBank	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	RITONAVIR		NCI	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	3-Hydroxy-Myristic Acid		DrugBank	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	SCV-07		DrugBank	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	FOLIC ACID		PharmGKB	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	Eritoran		DrugBank	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	ERITORAN		TdgClinicalTrial	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	INFLIXIMAB		NCI	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
TLR4	NELFINAVIR		NCI	Cell surface,druggable genome,external side of plasma membrane,kinase,serine threonine kinase
NR1H3	22R-HYDROXYCHOLESTEROL	agonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	24(S), 25-EPOXYCHOLESTEROL	agonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	24(S)-HYDROXYCHOLESTEROL	agonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	DESMOSTEROL	agonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	GW3965	agonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	L-783483	agonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	PAXILLINE	agonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	T0901317	agonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE		DrugBank	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	GSK2033	antagonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	CS-8080	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	LXR-623	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	HYODEOXYCHOLIC_ACID	agonist	ChemblInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	BMS-852927	modulator	ChemblInteractions	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE		DrugBank	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID		DrugBank	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE		DrugBank	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	VERAPAMIL		PharmGKB	Druggable genome,nuclear hormone receptor,transcription factor complex
NR1H3	ATENOLOL		PharmGKB	Druggable genome,nuclear hormone receptor,transcription factor complex
KLC1	FLUOROURACIL		PharmGKB	
MARK3	7-HYDROXYSTAUROSPORINE	inhibitor	TTD	Druggable genome,kinase,serine threonine kinase
CCT3	Phosphoaminophosphonic Acid-Adenylate Ester		DrugBank	
SIK3	ARN-3236	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
SIK3	BOSUTINIB	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
SIK3	DASATINIB	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
SIK3	HMG COA REDUCTASE INHIBITORS		PharmGKB	Druggable genome,kinase,serine threonine kinase
SIK3	HMG COA REDUCTASE INHIBITORS		PharmGKB	Druggable genome,kinase,serine threonine kinase
MCOLN3	SF-11	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
MCOLN3	SF-21	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
MCOLN3	SN-1	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
ABCC1	SULFINPYRAZONE		TdgClinicalTrial	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	Sulfinpyrazone	inhibitor	DrugBank	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	SULFINPYRAZONE		TEND	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	SULFINPYRAZONE	modulator	TTD	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	BIRICODAR	modulator	TTD	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	BENZBROMARONE	stimulator	TTD	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	THYMIDINE		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	DIPYRIDAMOLE		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	CDDP		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	VM-26		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	PILOCARPINE		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	PSC-833		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	OFLOXACIN		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	MELPHALAN		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	ERYTHROMYCIN		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	CPT-11		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	NOVOBIOCIN		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	PIRARUBICIN		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	BUTHIONINE SULFOXIMINE		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	MONTELUKAST		PharmGKB	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	AZITHROMYCIN		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	CSA		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	CYCLOSPORIN A		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	LAMIVUDINE		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	EGCG		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	PROBENECID		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	DROLOXIFENE		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	FLAVOPIRIDOL		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	ETOPOSIDE		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	VP-16		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	DAUNORUBICIN		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	SAQUINAVIR MESYLATE		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	TROXACITABINE		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	RITONAVIR		NCI	Abc transporter,drug resistance,druggable genome,transporter
ABCC1	SODIUM BUTYRATE		NCI	Abc transporter,drug resistance,druggable genome,transporter
P2RX7	EVT401	antagonist	ChemblInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	EVT-401		TdgClinicalTrial	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	ATP	agonist	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	AZ11645373	allosteric modulator	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	CHELERYTHRINE	allosteric modulator	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	GW791343	allosteric modulator	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	KN62	allosteric modulator	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	IVERMECTIN	allosteric modulator	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	A438079	antagonist	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	A740003	antagonist	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	A804598	antagonist	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	AZ11657312 (SALT FREE)	antagonist	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	DECAVANADATE	antagonist	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	JNJ-479655	antagonist	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	PF-04905428	antagonist	GuideToPharmacologyInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	GSK1482160	antagonist	TTD	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	GSK1482160		ChemblInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	AZD9056	antagonist	TTD	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	AZD9056	antagonist	ChemblInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
P2RX7	CE-224535	antagonist	ChemblInteractions	Cell surface,drug resistance,druggable genome,external side of plasma membrane,ion channel,kinase,serine threonine kinase,transporter
MAPK10	BRIMAPITIDE	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
MAPK10	GNE-3511	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
MAPK10	JNK-IN-8	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
MAPK10	JNK INHIBITOR IX	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
MAPK10	JNK INHIBITOR V	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
MAPK10	JNK INHIBITOR VIII	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
MAPK10	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	SP600125	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase
MAPK10	Bentamapimod	inhibitor	ChemblInteractions	Druggable genome,kinase,serine threonine kinase
MAPK10	CC-401	inhibitor	ChemblInteractions	Druggable genome,kinase,serine threonine kinase
MAPK10	TANZISERTIB	inhibitor	ChemblInteractions	Druggable genome,kinase,serine threonine kinase
MAPK10	IRINOTECAN		NCI	Druggable genome,kinase,serine threonine kinase
MAPK10	RAPAMYCIN		NCI	Druggable genome,kinase,serine threonine kinase
MAPK10	4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	WORTMANNIN		NCI	Druggable genome,kinase,serine threonine kinase
MAPK10	ISOPROTERENOL		NCI	Druggable genome,kinase,serine threonine kinase
MAPK10	PD-98059		NCI	Druggable genome,kinase,serine threonine kinase
MAPK10	N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	9-(4-Hydroxyphenyl)-2,7-Phenanthroline		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	MITOMYCIN-C		NCI	Druggable genome,kinase,serine threonine kinase
MAPK10	Phosphoaminophosphonic Acid-Adenylate Ester		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	NORDIHYDROGUAIARETIC ACID		NCI	Druggable genome,kinase,serine threonine kinase
MAPK10	ARSENIC TRIOXIDE		NCI	Druggable genome,kinase,serine threonine kinase
MAPK10	1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	EPINEPHRINE		NCI	Druggable genome,kinase,serine threonine kinase
MAPK10	N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine		DrugBank	Druggable genome,kinase,serine threonine kinase
MAPK10	ATORVASTATIN		NCI	Druggable genome,kinase,serine threonine kinase
ATP8A1	Phosphatidyl serine		DrugBank	Abc transporter,transporter
SUCLG2	Succinic acid		DrugBank	
ZEB1	SALINOMYCIN		CIViC	Transcription factor binding,transcription factor complex
ZEB1	DOXORUBICIN		CIViC	Transcription factor binding,transcription factor complex
XRCC4	DOCETAXEL		PharmGKB	Dna repair
KCNMB4	Miconazole	inhibitor	DrugBank	Ion channel,transporter
PIK3R4	GDC-0980	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	BYL719	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	BYL719	inhibitor	MyCancerGenomeClinicalTrial	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	GDC-0941	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	GSK2636771	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	PF-4691502	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	PI-103	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	PKI-587	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	PKI-587	inhibitor	MyCancerGenomeClinicalTrial	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	PX-866	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	PX-866	inhibitor	MyCancerGenomeClinicalTrial	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	SF1126	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	SOPHORETIN	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	BAY80-6946	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	BAY80-6946	inhibitor	MyCancerGenomeClinicalTrial	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	BUPARLISIB HYDROCHLORIDE	inhibitor	MyCancerGenomeClinicalTrial	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	XL147	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	DACTOLISIB	inhibitor	MyCancerGenomeClinicalTrial	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	BEZ235	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	BKM120	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	XL-765	inhibitor	MyCancerGenome	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
PIK3R4	GSK2126458	inhibitor	MyCancerGenomeClinicalTrial	Druggable genome,kinase,lipid kinase,phosphatidylinositol 3 kinase,serine threonine kinase,tumor suppressor
LAMA3	OCRIPLASMIN		ChemblInteractions	Druggable genome
KCNQ1	Indapamide	inhibitor	DrugBank	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	INDAPAMIDE		TdgClinicalTrial	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	INDAPAMIDE		TEND	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	INDAPAMIDE	blocker	TTD	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	Bepridil	inhibitor	DrugBank	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	BEPRIDIL		TEND	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	BEPRIDIL		TdgClinicalTrial	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	ML277	activator	GuideToPharmacologyInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	MEFENAMIC ACID	activator	GuideToPharmacologyInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	R-L3	activator	GuideToPharmacologyInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	NIFLUMIC ACID	activator	GuideToPharmacologyInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	HMR-1556	channel blocker	GuideToPharmacologyInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	XE991	channel blocker	GuideToPharmacologyInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	L735821	channel blocker	GuideToPharmacologyInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	NERISPIRDINE	blocker	TTD	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	NERISPIRDINE	blocker	ChemblInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	GUANIDINE HYDROCHLORIDE	blocker	ChemblInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	TEDISAMIL	blocker	ChemblInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	DALFAMPRIDINE	blocker	ChemblInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	RETIGABINE		TdgClinicalTrial	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	EZOGABINE	blocker	ChemblInteractions	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	DOLASETRON		NCI	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	INDOMETHACIN		TdgClinicalTrial	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	TACROLIMUS		PharmGKB	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	CELECOXIB		PharmGKB	Drug resistance,druggable genome,ion channel,transporter
KCNQ1	Azimilide		DrugBank	Drug resistance,druggable genome,ion channel,transporter
ATP2A2	ENOXACIN	inhibitor	GuideToPharmacologyInteractions	Abc transporter,druggable genome,transporter
ATP2A2	ISTAROXIME		TdgClinicalTrial	Abc transporter,druggable genome,transporter
ATP2A2	CELECOXIB		PharmGKB	Abc transporter,druggable genome,transporter
KCNS3	GUANIDINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNS3	NERISPIRDINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNS3	DALFAMPRIDINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNS3	TEDISAMIL	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
LGR4	R-SPONDIN-3	agonist	GuideToPharmacologyInteractions	Druggable genome,g protein coupled receptor
NARS2	L-Asparagine		DrugBank	
GUCY1A2	Nitric Oxide	inducer	DrugBank	Druggable genome
GUCY1A2	NITRIC OXIDE		TdgClinicalTrial	Druggable genome
GUCY1A2	NITRIC OXIDE	activator	ChemblInteractions	Druggable genome
GUCY1A2	CINACIGUAT	activator	GuideToPharmacologyInteractions	Druggable genome
GUCY1A2	RIOCIGUAT	activator	GuideToPharmacologyInteractions	Druggable genome
GUCY1A2	Riociguat	agonist,stimulator	DrugBank	Druggable genome
GUCY1A2	RIOCIGUAT		TdgClinicalTrial	Druggable genome
GUCY1A2	RIOCIGUAT	positive allosteric modulator	ChemblInteractions	Druggable genome
GUCY1A2	ODQ	inhibitor	GuideToPharmacologyInteractions	Druggable genome
GUCY1A2	Methylene blue	antagonist	DrugBank	Druggable genome
GUCY1A2	Plecanatide	agonist	DrugBank	Druggable genome
GUCY1A2	NITROGLYCERIN	activator	ChemblInteractions	Druggable genome
GUCY1A2	ISOSORBIDE MONONITRATE	activator	ChemblInteractions	Druggable genome
GUCY1A2	ISOSORBIDE DINITRATE	activator	ChemblInteractions	Druggable genome
GUCY1A2	SODIUM NITROPRUSSIDE	activator	ChemblInteractions	Druggable genome
GUCY1A2	NAPROXCINOD		TdgClinicalTrial	Druggable genome
GUCY1A2	NCX 4016		TdgClinicalTrial	Druggable genome
SLC16A7	Pyruvic acid		DrugBank	Druggable genome,transporter
TRPC5	ROSIGLITAZONE	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TRPC5	CA2+	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TRPC5	DAIDZEIN	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TRPC5	GENISTEIN	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TRPC5	PB2+	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TRPC5	(-)-ENGLERIN A	agonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TRPC5	2-APB	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TRPC5	PROGESTERONE	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TRPC5	CHLORPROMAZINE	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TRPC5	FLUFENAMIC ACID	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TRPC5	ML204	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
KCNQ3	DALFAMPRIDINE	blocker	ChemblInteractions	Cell surface,druggable genome,ion channel,transporter
KCNQ3	NERISPIRDINE	blocker	ChemblInteractions	Cell surface,druggable genome,ion channel,transporter
KCNQ3	FLINDOKALNER	activator	ChemblInteractions	Cell surface,druggable genome,ion channel,transporter
KCNQ3	TEDISAMIL	blocker	ChemblInteractions	Cell surface,druggable genome,ion channel,transporter
KCNQ3	GUANIDINE HYDROCHLORIDE	blocker	ChemblInteractions	Cell surface,druggable genome,ion channel,transporter
KCNQ3	Ezogabine		DrugBank	Cell surface,druggable genome,ion channel,transporter
KCNQ3	RETIGABINE		TdgClinicalTrial	Cell surface,druggable genome,ion channel,transporter
KCNQ3	EZOGABINE	blocker	ChemblInteractions	Cell surface,druggable genome,ion channel,transporter
KCNQ3	CELECOXIB		PharmGKB	Cell surface,druggable genome,ion channel,transporter
KCNQ2	DALFAMPRIDINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ2	GUANIDINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ2	NERISPIRDINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ2	FLINDOKALNER	activator	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ2	TEDISAMIL	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ2	Ezogabine		DrugBank	Druggable genome,ion channel,transporter
KCNQ2	RETIGABINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
KCNQ2	EZOGABINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
KCNQ2	CELECOXIB		PharmGKB	Druggable genome,ion channel,transporter
CHST11	CHONDROITIN		NCI	Druggable genome
CHST11	CHONDROITIN SULFATE		NCI	Druggable genome
PDE10A	Dipyridamole	inhibitor	DrugBank	Druggable genome
PDE10A	DIPYRIDAMOLE	inhibitor	ChemblInteractions	Druggable genome
PDE10A	DIPYRIDAMOLE		TdgClinicalTrial	Druggable genome
PDE10A	DIPYRIDAMOLE		TEND	Druggable genome
PDE10A	Papaverine	inhibitor	DrugBank	Druggable genome
PDE10A	Tofisopam	inhibitor	DrugBank	Druggable genome
PDE10A	Triflusal	antagonist	DrugBank	Druggable genome
PDE10A	COMPOUND 19 [PMID: 22142545]	inhibitor	GuideToPharmacologyInteractions	Druggable genome
PDE10A	PF-2545920	inhibitor	GuideToPharmacologyInteractions	Druggable genome
PDE10A	PBF-999	inhibitor	ChemblInteractions	Druggable genome
PDE10A	PENTOXIFYLLINE	inhibitor	ChemblInteractions	Druggable genome
PDE10A	2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline		DrugBank	Druggable genome
PDE10A	4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole		DrugBank	Druggable genome
PDE10A	2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline		DrugBank	Druggable genome
PDE10A	6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE		DrugBank	Druggable genome
PDE10A	6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE		DrugBank	Druggable genome
PDE10A	2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline		DrugBank	Druggable genome
PDE6C	SILDENAFIL	inhibitor	GuideToPharmacologyInteractions	Druggable genome
PDE6C	PENTOXIFYLLINE	inhibitor	ChemblInteractions	Druggable genome
PDE6C	DIPYRIDAMOLE	inhibitor	ChemblInteractions	Druggable genome
GLRA2	Lindane	antagonist	DrugBank	Druggable genome,ion channel,transporter
GLRA2	PICROTOXIN		TEND	Druggable genome,ion channel,transporter
GLRA2	Picrotoxin	antagonist	DrugBank	Druggable genome,ion channel,transporter
GLRA2	Glycine		DrugBank	Druggable genome,ion channel,transporter
CUBN	Hydroxocobalamin	other	DrugBank	Cell surface,external side of plasma membrane,transporter
NMT2	1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL		DrugBank	Druggable genome
NMT2	Myristoyl-Coa		DrugBank	Druggable genome
ROCK1	HYDROXYFASUDIL	inhibitor	DrugBank	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	COMPOUND 33 [PMID: 19364658]	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE		DrugBank	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	FASUDIL	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	GSK269962A	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	GSK429286A	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	KD025	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	SAR407899	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	SAR407899	inhibitor	TTD	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	VEROSUDIL	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	VEROSUDIL	inhibitor	ChemblInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE		DrugBank	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	Y27632	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	Y-39983	inhibitor	ChemblInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	AMA0076	inhibitor	ChemblInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE		DrugBank	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	RHO-KINASE INHIBITOR	inhibitor	TTD	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	AT-13148	inhibitor	ChemblInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	CETHRIN	inhibitor	TTD	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	DE-104	inhibitor	ChemblInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
ROCK1	SAR-407899	inhibitor	ChemblInteractions	Druggable genome,kinase,protein phosphatase,serine threonine kinase
TXNRD1	ARSENIC TRIOXIDE		TEND	Druggable genome
TXNRD1	Arsenic trioxide	inhibitor	DrugBank	Druggable genome
TXNRD1	ARSENIC TRIOXIDE		TdgClinicalTrial	Druggable genome
TXNRD1	ARSENIC TRIOXIDE	inhibitor	ChemblInteractions	Druggable genome
TXNRD1	motexafin gadolinium		DrugBank	Druggable genome
TXNRD1	MOTEXAFIN GADOLINIUM		TdgClinicalTrial	Druggable genome
TXNRD1	PX-12		DrugBank	Druggable genome
TXNRD1	Flavin adenine dinucleotide		DrugBank	Druggable genome
TXNRD1	Spermidine		DrugBank	Druggable genome
TXNRD1	Fotemustine		DrugBank	Druggable genome
GRID1	L-Glutamic Acid		DrugBank	Druggable genome,ion channel,transporter
ADARB2	ACETIC ACID	agonist	GuideToPharmacologyInteractions	
ADARB2	BUTYRIC ACID	agonist	GuideToPharmacologyInteractions	
ADARB2	ISOBUTYRIC ACID	agonist	GuideToPharmacologyInteractions	
ADARB2	PENTANOIC ACID	agonist	GuideToPharmacologyInteractions	
ADARB2	PROPANOIC ACID	agonist	GuideToPharmacologyInteractions	
CPQ	L-Glutamic Acid		DrugBank	Druggable genome,neutral zinc metallopeptidase,protease
CACNA2D1	Isradipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA2D1	ISRADIPINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA2D1	ISRADIPINE	blocker	TTD	Druggable genome,ion channel,transporter
CACNA2D1	ISRADIPINE		TEND	Druggable genome,ion channel,transporter
CACNA2D1	Nisoldipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA2D1	Gabapentin	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA2D1	GABAPENTIN		TEND	Druggable genome,ion channel,transporter
CACNA2D1	GABAPENTIN		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA2D1	GABAPENTIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA2D1	Felodipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA2D1	FELODIPINE		TEND	Druggable genome,ion channel,transporter
CACNA2D1	FELODIPINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA2D1	Nitrendipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA2D1	NITRENDIPINE	blocker	TTD	Druggable genome,ion channel,transporter
CACNA2D1	Nifedipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA2D1	NIFEDIPINE	blocker	TTD	Druggable genome,ion channel,transporter
CACNA2D1	NIFEDIPINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA2D1	NIFEDIPINE		TEND	Druggable genome,ion channel,transporter
CACNA2D1	Cyclandelate	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA2D1	Nilvadipine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
CACNA2D1	DILTIAZEM	blocker	TTD	Druggable genome,ion channel,transporter
CACNA2D1	AMLODIPINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA2D1	AMLODIPINE	blocker	TTD	Druggable genome,ion channel,transporter
CACNA2D1	LERCANIDIPINE	blocker	TTD	Druggable genome,ion channel,transporter
CACNA2D1	BEPRIDIL HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA2D1	GABAPENTIN ENACARBIL	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA2D1	XP13512		DrugBank	Druggable genome,ion channel,transporter
CACNA2D1	XP13512		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA2D1	PREGABALIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA2D1	MIROGABALIN BESYLATE	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA2D1	IMAGABALIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA2D1	ATAGABALIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNA2D1	SAFINAMIDE		TdgClinicalTrial	Druggable genome,ion channel,transporter
CACNA2D1	CELECOXIB		PharmGKB	Druggable genome,ion channel,transporter
CACNA2D1	Magnesium Sulfate		DrugBank	Druggable genome,ion channel,transporter
CACNA2D1	IBUTILIDE		TEND	Druggable genome,ion channel,transporter
CACNA2D1	IBUTILIDE		TdgClinicalTrial	Druggable genome,ion channel,transporter
SCN9A	PHENACEMIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PHENYTOIN SODIUM	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	ETIDOCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PHENYTOIN	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	LIDOCAINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	LIDOCAINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
SCN9A	LIDOCAINE		TEND	Druggable genome,ion channel,transporter
SCN9A	RG7893	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	MERETHOXYLLINE PROCAINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	CHLOROPROCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	ORPHENADRINE CITRATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	RANOLAZINE		TdgClinicalTrial	Druggable genome,ion channel,transporter
SCN9A	Ranolazine	inhibitor	DrugBank	Druggable genome,ion channel,transporter
SCN9A	RANOLAZINE	blocker	TTD	Druggable genome,ion channel,transporter
SCN9A	Zonisamide	inhibitor	DrugBank	Druggable genome,ion channel,transporter
SCN9A	ZONISAMIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	ZONISAMIDE		TdgClinicalTrial	Druggable genome,ion channel,transporter
SCN9A	Rufinamide	modulator	DrugBank	Druggable genome,ion channel,transporter
SCN9A	RUFINAMIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	VERATRIDINE	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
SCN9A	Lacosamide		DrugBank	Druggable genome,ion channel,transporter
SCN9A	LACOSAMIDE	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
SCN9A	LACOSAMIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PYRROLOPYRIMIDINE 48 [PMID: 22318156]	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
SCN9A	CD2+	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
SCN9A	SAXITOXIN	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
SCN9A	TETRODOTOXIN		TdgClinicalTrial	Druggable genome,ion channel,transporter
SCN9A	TETRODOTOXIN	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
SCN9A	ESLICARBAZEPINE ACETATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	QUINIDINE POLYGALACTURONATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	MEXILETINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	RILUZOLE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	HEXYLCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PRIMIDONE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	ETHOTOIN	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	DISOPYRAMIDE PHOSPHATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	DRONEDARONE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	DYCLONINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	QUINIDINE SULFATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PRILOCAINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	TOPIRAMATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PROCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	MORICIZINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PROPOXYCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	OXCARBAZEPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	FOSPHENYTOIN SODIUM	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	LAMOTRIGINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	LIDOCAINE HYDROCHLORIDE HYDRATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	TOCAINIDE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	NW-3509	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	AZD3161	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	XEN403	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	DSP-2230	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	NKTR-171	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	RG6029	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PF-05089771	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	RAXATRIGINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	NERISPIRDINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	RALFINAMIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	TETRACAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	ESLICARBAZEPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	MEPIVACAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PROCAINAMIDE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	MEPHENYTOIN	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	ROPIVACAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PROPARACAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	INDECAINIDE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PHENAZOPYRIDINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	QUINIDINE GLUCONATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	ORPHENADRINE (CHLORIDE)	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PRILOCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	IRAMPANEL	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	BENOXINATE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	ARTICAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	PROPAFENONE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	TETRACAINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	CARBAMAZEPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN9A	SAFINAMIDE		TdgClinicalTrial	Druggable genome,ion channel,transporter
SCN9A	XEN402		TdgClinicalTrial	Druggable genome,ion channel,transporter
FNTB	BMS-214662	inhibitor	GuideToPharmacologyInteractions	Druggable genome,tumor suppressor
FNTB	FTI 276	inhibitor	GuideToPharmacologyInteractions	Druggable genome,tumor suppressor
FNTB	L-739,750	inhibitor	GuideToPharmacologyInteractions	Druggable genome,tumor suppressor
FNTB	TIPIFARNIB	inhibitor	GuideToPharmacologyInteractions	Druggable genome,tumor suppressor
FNTB	Tipifarnib		DrugBank	Druggable genome,tumor suppressor
FNTB	TIPIFARNIB	inhibitor	ChemblInteractions	Druggable genome,tumor suppressor
FNTB	TIPIFARNIB		TdgClinicalTrial	Druggable genome,tumor suppressor
FNTB	LONAFARNIB	inhibitor	ChemblInteractions	Druggable genome,tumor suppressor
FNTB	GERANYLGERANYL DIPHOSPHATE		DrugBank	Druggable genome,tumor suppressor
FNTB	(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE		DrugBank	Druggable genome,tumor suppressor
FNTB	FARNESYL DIPHOSPHATE		DrugBank	Druggable genome,tumor suppressor
FNTB	4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE		DrugBank	Druggable genome,tumor suppressor
AKR1A1	FOMEPIZOLE	inhibitor	TTD	Druggable genome
AKR1A1	2'-Monophosphoadenosine 5'-Diphosphoribose		DrugBank	Druggable genome
AKR1A1	Tolrestat		DrugBank	Druggable genome
RORA	7-HYDROXYCHOLESTEROL	agonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor binding
RORA	Cholesterol		DrugBank	Druggable genome,nuclear hormone receptor,transcription factor binding
RORA	CHOLESTEROL	agonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor binding
RORA	Cholesterol-Sulfate		DrugBank	Druggable genome,nuclear hormone receptor,transcription factor binding
RORA	CHOLESTEROL SULPHATE	agonist	GuideToPharmacologyInteractions	Druggable genome,nuclear hormone receptor,transcription factor binding
RORA	MELATONIN		NCI	Druggable genome,nuclear hormone receptor,transcription factor binding
ACADM	Octanoyl-Coenzyme A		DrugBank	
ACADM	Flavin adenine dinucleotide		DrugBank	
MAP3K5	MSC2032964A	inhibitor	GuideToPharmacologyInteractions	Cell surface,druggable genome,external side of plasma membrane,kinase,protease,serine threonine kinase
MAP3K5	GS-4997	inhibitor	ChemblInteractions	Cell surface,druggable genome,external side of plasma membrane,kinase,protease,serine threonine kinase
PLA2G4A	Quinacrine	inhibitor	DrugBank	Druggable genome,lipase,phospholipase
PLA2G4A	FLUTICASONE PROPIONATE		TEND	Druggable genome,lipase,phospholipase
PLA2G4A	Niflumic Acid		DrugBank	Druggable genome,lipase,phospholipase
PLA2G4A	FLUOCINOLONE ACETONIDE		TEND	Druggable genome,lipase,phospholipase
PLA2G4A	FLUOCINONIDE		TEND	Druggable genome,lipase,phospholipase
PLA2G4A	FLUNISOLIDE		TEND	Druggable genome,lipase,phospholipase
PLA2G4A	FLURANDRENOLIDE		TEND	Druggable genome,lipase,phospholipase
PLA2G4A	MEDRYSONE		TEND	Druggable genome,lipase,phospholipase
PLA2G4A	FLUOROMETHOLONE		TEND	Druggable genome,lipase,phospholipase
GABRD	ESTAZOLAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	Estazolam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	ESTAZOLAM		TEND	Druggable genome,ion channel,transporter
GABRD	ESTAZOLAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	TEMAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	Temazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	TEMAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	TEMAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	ADINAZOLAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	Adinazolam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	ADINAZOLAM		TEND	Druggable genome,ion channel,transporter
GABRD	HALAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	Halazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	HALAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	HALAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	Diazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	DIAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	DIAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	DIAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	OXAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	OXAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	Oxazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	OXAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	Triazolam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	TRIAZOLAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	TRIAZOLAM		TEND	Druggable genome,ion channel,transporter
GABRD	TRIAZOLAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	GABOXADOL	agonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GABRD	PICROTOXIN	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GABRD	TBPS	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GABRD	Bromazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	BROMAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	BROMAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	Clotiazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	CLOTIAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	CLOTIAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	Fludiazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	FLUDIAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	FLUDIAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	Ketazolam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	Prazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	PRAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	PRAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	PRAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	Quazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	QUAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	QUAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	QUAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	Cinolazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	CINOLAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	CINOLAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	Nitrazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRD	NITRAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	NITRAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	CLORAZEPATE DIPOTASSIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	CHLORDIAZEPOXIDE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	CHLORDIAZEPOXIDE		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	CHLORDIAZEPOXIDE		TEND	Druggable genome,ion channel,transporter
GABRD	CHLORDIAZEPOXIDE HYDROCHLORIDE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	MEPROBAMATE	agonist	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	ALPRAZOLAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	ALPRAZOLAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	ALPRAZOLAM		TEND	Druggable genome,ion channel,transporter
GABRD	CLONAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	CLONAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	CLONAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	DESFLURANE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	TALBUTAL	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	BUTABARBITAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	LORAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	LORAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	LORAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	METHARBITAL	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	METHYPRYLON	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	MIDAZOLAM HYDROCHLORIDE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	PRIMIDONE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	PENTOBARBITAL	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	PENTOBARBITAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	SECOBARBITAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	THIAMYLAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	THIOPENTAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	FLURAZEPAM HYDROCHLORIDE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	HALOTHANE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	ISOFLURANE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	PF-06372865	agonist	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	BUTALBITAL	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	CLOBAZAM		TEND	Druggable genome,ion channel,transporter
GABRD	CLOBAZAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	CLOBAZAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	SEVOFLURANE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	PROPOFOL	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	METHOHEXITAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	ESZOPICLONE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	GLUTETHIMIDE		ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	ENFLURANE		ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	OCINAPLON		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	NG2-73		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	TRICLOFOS SODIUM		ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	MIDAZOLAM		TEND	Druggable genome,ion channel,transporter
GABRD	MIDAZOLAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	ETOMIDATE		ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	METHOXYFLURANE		ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	ACAMPROSATE CALCIUM		ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	FLURAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRD	FLURAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	FLUMAZENIL		ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	ETHCHLORVYNOL		ChemblInteractions	Druggable genome,ion channel,transporter
GABRD	CLORAZEPATE		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRD	CLORAZEPATE		TEND	Druggable genome,ion channel,transporter
GABRD	TOPIRAMATE		ChemblInteractions	Druggable genome,ion channel,transporter
RAF1	RG-7376	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	XL-281	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	XL281		DrugBank	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	XL281	inhibitor	MyCancerGenome	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	XL281		TdgClinicalTrial	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	SORAFENIB		TdgClinicalTrial	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	Sorafenib	inhibitor	DrugBank	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	SORAFENIB	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	Sorafenib		OncoKB	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	SORAFENIB	inhibitor	MyCancerGenome	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	SORAFENIB		TEND	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	SORAFENIB	inhibitor	MyCancerGenomeClinicalTrial	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	Sorafenib		CGI	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	REGORAFENIB	inhibitor	MyCancerGenomeClinicalTrial	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	Regorafenib	inhibitor	DrugBank	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	REGORAFENIB	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	REGORAFENIB	inhibitor	MyCancerGenome	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	Dabrafenib	inhibitor	DrugBank	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	CEP-32496	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	GW5074	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	L779450	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	LY3009120	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	LY-3009120	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	OSI-930	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	PLX8394	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	SB590885	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	VEMURAFENIB	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	ZM336372	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	ARQ736	inhibitor	TALC	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	ARQ-736	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	LGX-806	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	LGX818	inhibitor	MyCancerGenome	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	MLN-2480	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	1096708-71-2	inhibitor	MyCancerGenomeClinicalTrial	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	SORAFENIB TOSYLATE	inhibitor	MyCancerGenomeClinicalTrial	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	SORAFENIB TOSYLATE	inhibitor	MyCancerGenomeClinicalTrial	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	SORAFENIB TOSYLATE	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	CHIR-265		TdgClinicalTrial	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
RAF1	U0126		CGI	Clinically actionable,druggable genome,kinase,protease,serine threonine kinase
PROZ	MENADIONE		TEND	Druggable genome,protease
PROZ	Menadione	activator	DrugBank	Druggable genome,protease
MYH14	(S)-blebbistatin		DrugBank	
SLC44A1	HEMICHOLINIUM-3	inhibitor	GuideToPharmacologyInteractions	Druggable genome,transporter
MARK2	APAP		NCI	Druggable genome,kinase,serine threonine kinase
NGF	Clenbuterol	stimulator	DrugBank	Druggable genome,growth factor,kinase,neutral zinc metallopeptidase,protease,protease inhibitor,serine threonine kinase
NGF	FULRANUMAB	inhibitor	ChemblInteractions	Druggable genome,growth factor,kinase,neutral zinc metallopeptidase,protease,protease inhibitor,serine threonine kinase
NGF	Fasinumab	inhibitor	ChemblInteractions	Druggable genome,growth factor,kinase,neutral zinc metallopeptidase,protease,protease inhibitor,serine threonine kinase
NGF	TANEZUMAB		TdgClinicalTrial	Druggable genome,growth factor,kinase,neutral zinc metallopeptidase,protease,protease inhibitor,serine threonine kinase
NGF	TANEZUMAB	inhibitor	ChemblInteractions	Druggable genome,growth factor,kinase,neutral zinc metallopeptidase,protease,protease inhibitor,serine threonine kinase
NGF	METHADONE		PharmGKB	Druggable genome,growth factor,kinase,neutral zinc metallopeptidase,protease,protease inhibitor,serine threonine kinase
NGF	PG110		TdgClinicalTrial	Druggable genome,growth factor,kinase,neutral zinc metallopeptidase,protease,protease inhibitor,serine threonine kinase
NCOA2	2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE		DrugBank	Transcription factor binding
NCOA2	N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE		DrugBank	Transcription factor binding
NCOA2	tributylstannanyl		DrugBank	Transcription factor binding
NCOA2	RALOXIFENE CORE		DrugBank	Transcription factor binding
NCOA2	2-chloro-5-nitro-N-phenylbenzamide		DrugBank	Transcription factor binding
NCOA2	(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID		DrugBank	Transcription factor binding
NCOA2	dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate		DrugBank	Transcription factor binding
NCOA2	Genistein		DrugBank	Transcription factor binding
NCOA2	4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol		DrugBank	Transcription factor binding
NCOA2	Methyltrienolone		DrugBank	Transcription factor binding
NCOA2	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL		DrugBank	Transcription factor binding
NCOA2	4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL		DrugBank	Transcription factor binding
NCOA2	2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID		DrugBank	Transcription factor binding
NCOA2	3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL		DrugBank	Transcription factor binding
NCOA2	3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL		DrugBank	Transcription factor binding
RUNX1	RN-1		CKB	Clinically actionable
RUNX1	Doxorubicin		CKB	Clinically actionable
RUNX1	CYTARABINE		CIViC	Clinically actionable
RUNX1	METHACHOLINE CHLORIDE		PharmGKB	Clinically actionable
GRIK1	LY293558	antagonist	TTD	Druggable genome,ion channel,transporter
GRIK1	TEZAMPANEL	antagonist	ChemblInteractions	Druggable genome,ion channel,transporter
GRIK1	TEZAMPANEL		TdgClinicalTrial	Druggable genome,ion channel,transporter
GRIK1	TOPIRAMATE		TdgClinicalTrial	Druggable genome,ion channel,transporter
GRIK1	TOPIRAMATE	antagonist	ChemblInteractions	Druggable genome,ion channel,transporter
GRIK1	Topiramate	antagonist	DrugBank	Druggable genome,ion channel,transporter
GRIK1	TOPIRAMATE	antagonist	TTD	Druggable genome,ion channel,transporter
GRIK1	TOPIRAMATE		TEND	Druggable genome,ion channel,transporter
GRIK1	(S)-5-IODOWILLARDIINE	agonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	LY339434	agonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	8-DEOXY-NEODYSIHERBAINE	agonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	ATPA	agonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	DOMOIC ACID	agonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	(S)-4-AHCP	agonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	KAINATE	agonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	[3H]SYM2081	agonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	SYM2081	agonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	CONCANAVALIN A	allosteric modulator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	ACET	antagonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	LY382884	antagonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	NS3763	antagonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	[3H]UBP310	antagonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	UBP310	antagonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	UBP302	antagonist	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GRIK1	DASOLAMPANEL	antagonist	ChemblInteractions	Druggable genome,ion channel,transporter
GRIK1	Selurampanel	antagonist	ChemblInteractions	Druggable genome,ion channel,transporter
GRIK1	NS-1209		TdgClinicalTrial	Druggable genome,ion channel,transporter
GRIK1	L-Glutamic Acid		DrugBank	Druggable genome,ion channel,transporter
SLC25A22	L-Glutamic Acid		DrugBank	Druggable genome,transporter
AGER	VITAMIN B12		NCI	Druggable genome,kinase,serine threonine kinase
CAMK1G	5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE		DrugBank	Druggable genome,kinase,serine threonine kinase
RBMS3	BISPHOSPHONATES		PharmGKB	
FGF2	Sucralfate	agonist	DrugBank	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	PENTOSAN POLYSULFATE		TdgClinicalTrial	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	Pentosan Polysulfate	antagonist	DrugBank	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	PENTOSAN POLYSULFATE		TEND	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	PENTOSAN POLYSULFATE		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	MUPARFOSTAT	inhibitor	ChemblInteractions	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	ABT-510		DrugBank	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	ABT-510		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	INDOMETHACIN		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	LAK CELLS		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	PHENYLEPHRINE		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	ATORVASTATIN		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	ESTRADIOL DIPROPIONATE		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	ASPIRIN		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	QUIZARTINIB (AC220)		CIViC	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	FAMOTIDINE		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	TRIAMCINOLONE		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	CAFFEINE		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	VINCRISTINE		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	BISPHOSPHONATES		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	Sirolimus		DrugBank	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	SIROLIMUS		TdgClinicalTrial	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	ICI 182,780		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	THYROTROPIN		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	PYRAZOLE		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
FGF2	REBAMIPIDE		NCI	Druggable genome,growth factor,kinase,lipid kinase,phospholipase,serine threonine kinase,tyrosine kinase
ESR1	4-HYDROXYTAMOXIFEN	agonist,antagonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	HYDROXYTAMOXIFEN		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIARYLPROPIONITRILE	agonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIETHYLSTILBESTROL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Diethylstilbestrol	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIETHYLSTILBESTROL	agonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIETHYLSTILBESTROL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIETHYLSTILBESTROL	agonist	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIETHYLSTILBESTROL	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CHLOROTRIANISENE	binder	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Chlorotrianisene	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CHLOROTRIANISENE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CHLOROTRIANISENE		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTROGENS, CONJUGATED	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Conjugated Equine Estrogens	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CONJUGATED ESTROGENS		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CONJUGATED ESTROGENS		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ETONOGESTREL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Etonogestrel	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ETONOGESTREL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Desogestrel	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DESOGESTREL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DESOGESTREL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Levonorgestrel	other	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	LEVONORGESTREL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	LEVONORGESTREL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	PROGESTERONE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Progesterone	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	PROGESTERONE		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TOREMIFENE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TOREMIFENE		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Toremifene	modulator	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TOREMIFENE	modulator	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Medroxyprogesterone acetate	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	MEDROXYPROGESTERONE		PharmGKB	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRONE	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Estrone	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRONE	agonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRONE	agonist	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRONE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRONE		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TAMOXIFEN	agonist,antagonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Tamoxifen		FDA	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Tamoxifen	agonist,antagonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TAMOXIFEN		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TAMOXIFEN	antagonist	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TAMOXIFEN		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TAMOXIFEN		ClearityFoundationClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TAMOXIFEN		ClearityFoundationBiomarkers	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Tamoxifen		CGI	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TAMOXIFEN		CIViC	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIENESTROL	agonist	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIENESTROL	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Dienestrol	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIENESTROL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIENESTROL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Fulvestrant	antagonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	FULVESTRANT	antagonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	FULVESTRANT	antagonist	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Fulvestrant		CGI	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	FULVESTRANT		CIViC	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	FULVESTRANT	antagonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Fulvestrant		FDA	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Fulvestrant		OncoKB	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	FULVESTRANT	antagonist	TALC	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	FULVESTRANT		PharmGKB	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	FULVESTRANT		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	FULVESTRANT		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Fluvestrant		CGI	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Norgestimate	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	NORGESTIMATE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	NORGESTIMATE		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ETHINYLESTRADIOL	agonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ETHINYL ESTRADIOL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Ethinyl Estradiol	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ETHINYL ESTRADIOL	agonist	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ETHINYL ESTRADIOL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ETHINYL ESTRADIOL	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Melatonin	antagonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Trilostane	allosteric modulator	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Fluoxymesterone	antagonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Estramustine	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRIOL	agonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Estriol	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRIOL	agonist	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRIOL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRIOL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	PRINABEREL	agonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	PROPYLPYRAZOLETRIOL	agonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	RALOXIFENE	agonist,antagonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	RALOXIFENE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	RALOXIFENE		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	RALOXIFENE	modulator	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	R,R-THC	agonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	WAY200070	agonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	LASOFOXIFENE	agonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Lasofoxifene		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	LASOFOXIFENE	modulator	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	LASOFOXIFENE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	BAZEDOXIFENE	antagonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Bazedoxifene	agonist,antagonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	BAZEDOXIFENE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CLOMIPHENE	antagonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CLOMIFENE	modulator	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	GSK5182	antagonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	HEXESTROL	antagonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	METHYL-PIPERIDINO-PYRAZOLE	antagonist	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	MESTRANOL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Mestranol	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	MESTRANOL	agonist	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	MESTRANOL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	MESTRANOL	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Danazol	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DANAZOL	antagonist	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DANAZOL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DANAZOL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Allylestrenol	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Prasterone	binder	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Estrone sulfate	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTROPIPATE	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Quinestrol	agonist,modulator	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	QUINESTROL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	QUINESTROL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	QUINESTROL	modulator	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	QUINESTROL	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	OSPEMIFENE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Ospemifene	agonist,antagonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	OSPEMIFENE	modulator	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	OSPEMIFENE	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Tibolone	agonist	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Synthetic Conjugated Estrogens, A	ligand	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTROGENS, CONJUGATED SYNTHETIC A	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Synthetic Conjugated Estrogens, B	ligand	DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	SYNTHETIC CONJUGATED ESTROGENS, B	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	17-BETA ESTRADIOL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRADIOL	agonist	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRADIOL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRADIOL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRADIOL	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	MITOTANE	binder	TTD	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	SR16234	antagonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TAS-108		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	FISPEMIFENE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	FISPEMIFENE	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	LY2245461	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	IDOXIFENE	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	GTx-758	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	AFIMOXIFENE	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DROLOXIFENE	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ACOLBIFENE	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TAMOXIFEN CITRATE	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRADIOL VALERATE	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CLOMIPHENE CITRATE	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRADIOL CYPIONATE	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTROGENS, ESTERIFIED	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIETHYLSTILBESTROL DIPHOSPHATE	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	TOREMIFENE CITRATE	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	BAZEDOXIFENE ACETATE	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CHF 4227		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CHF 4227		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CHF4227	modulator	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	[GDC-0810]		CGI	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	GDC-0810		OncoKB	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	GDC-0810	antagonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTRADIOL ACETATE	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	POLYESTRADIOL PHOSPHATE	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	MK-6913		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	MK-6913	agonist	ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	DIENOGEST		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	RAD1901		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	RAD1901		ChemblInteractions	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Ribociclib		FDA	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	RALOXIFENE CORE		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ENDOXIFEN		ClearityFoundationClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CONJUGATED ESTROGENS		PharmGKB	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Letrozole		FDA	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	LETROZOLE		ClearityFoundationBiomarkers	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Letrozole		CGI	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	LETROZOLE		CIViC	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CISPLATIN		PharmGKB	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	EC145		ClearityFoundationClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	CC-8490		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Compound 4-D		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Everolimus		FDA	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Everolimus		CGI	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ESTROGEN		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ARZOXIFENE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Genistein		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Trastuzumab		FDA	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	A-007		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Palbociclib		FDA	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Palbociclib		CGI	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	PALBOCICLIB (PD0332991)		CIViC	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	LEFLUNOMIDE		PharmGKB	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	LHRH		CGI	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	NORGESTREL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	NORGESTREL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Compound 18		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Compound 19		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ETHYNODIOL DIACETATE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ETHYNODIOL DIACETATE		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	MEGESTROL		TEND	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	MEGESTROL		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Lapatinib		FDA	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	IODINE		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Pertuzumab		FDA	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	RALOXIFEN		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Abemaciclib		CGI	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	EXEMESTANE		PharmGKB	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Exemestane		CGI	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Exemestane		FDA	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL		DrugBank	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	NORELGESTROMIN		TdgClinicalTrial	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	ANASTROZOLE		ClearityFoundationBiomarkers	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Anastrozole		FDA	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
ESR1	Anastrozole		CGI	Clinically actionable,druggable genome,nuclear hormone receptor,phospholipase,transcription factor binding
GRIK3	Selurampanel	antagonist	ChemblInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
GRIK3	TEZAMPANEL	antagonist	ChemblInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
GRIK3	TEZAMPANEL		TdgClinicalTrial	Druggable genome,g protein coupled receptor,ion channel,transporter
GRIK3	TOPIRAMATE	antagonist	ChemblInteractions	Druggable genome,g protein coupled receptor,ion channel,transporter
GRIK3	L-Glutamic Acid		DrugBank	Druggable genome,g protein coupled receptor,ion channel,transporter
PRKG1	GSK690693	inhibitor	GuideToPharmacologyInteractions	Druggable genome,ion channel,kinase,serine threonine kinase,transporter
PRKG1	IPATASERTIB	inhibitor	GuideToPharmacologyInteractions	Druggable genome,ion channel,kinase,serine threonine kinase,transporter
DPYSL2	LACOSAMIDE		TdgClinicalTrial	
MAP4	Paclitaxel		DrugBank	
MAP4	Docetaxel		DrugBank	
CYP4B1	DEXTRAN SULFATE		NCI	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP4B1	THALIDOMIDE		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
CYP4B1	DOCETAXEL		PharmGKB	Cytochrome p450,drug metabolism,drug resistance,druggable genome
PDE6B	DIPYRIDAMOLE	inhibitor	ChemblInteractions	Druggable genome
PDE6B	PENTOXIFYLLINE	inhibitor	ChemblInteractions	Druggable genome
PREP	S 17092	inhibitor	GuideToPharmacologyInteractions	Druggable genome,protease
PREP	2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione		DrugBank	Druggable genome,protease
PREP	1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one		DrugBank	Druggable genome,protease
PREP	STZ		NCI	Druggable genome,protease
PREP	Z-Pro-Prolinal		DrugBank	Druggable genome,protease
PREP	Monothioglycerol		DrugBank	Druggable genome,protease
GPNMB	GLEMBATUMUMAB VEDOTIN		ChemblInteractions	Druggable genome,tumor suppressor
GSK3B	7-HYDROXYSTAUROSPORINE	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	ALSTERPAULLONE	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	Alsterpaullone		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	AZD1080	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	AZD-1080	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	BX-795	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	CDK1/5 INHIBITOR	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	CHIR-99021	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	COMPOUND 52 [PMID: 9677190]	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	COMPOUND 89S [PMID: 19115845]	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	GSK-3BETA INHIBITOR I	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	GSK-3 INHIBITOR XIII	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	INDIRUBIN-3'-MONOXIME	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	Indirubin-3'-Monoxime		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	ISOGRANULATIMIDE	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	KENPAULLONE	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	LY2090314	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	LY-2090314	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	RGB-286638	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	SB 216763	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	SB-415286	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	TWS119	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	TIDEGLUSIB	inhibitor	GuideToPharmacologyInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	TIDEGLUSIB		TdgClinicalTrial	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	Tideglusib	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	LITHIUM CITRATE HYDRATE	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	LITHIUM CARBONATE	inhibitor	ChemblInteractions	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	AT9283	inhibitor	TALC	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	ENZASTAURIN	inhibitor	TTD	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	I-5		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	Staurosporine		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	Phosphoaminophosphonic Acid-Adenylate Ester		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	FLUOXETINE		PharmGKB	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
GSK3B	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE		DrugBank	Clinically actionable,druggable genome,kinase,serine threonine kinase,transcription factor binding
B3GAT1	CHONDROITIN SULFATE		NCI	
B3GAT1	Uridine-5'-Diphosphate		DrugBank	
ESRRG	Troglitazone	inverse agonist	DrugBank	Druggable genome,nuclear hormone receptor
ESRRG	Diethylstilbestrol	agonist	DrugBank	Druggable genome,nuclear hormone receptor
ESRRG	DES		NCI	Druggable genome,nuclear hormone receptor
ESRRG	DIETHYLSTILBESTROL		NCI	Druggable genome,nuclear hormone receptor
ESRRG	AFIMOXIFENE	antagonist	ChemblInteractions	Druggable genome,nuclear hormone receptor
ESRRG	4,4'-cyclohexane-1,1-diyldiphenol		DrugBank	Druggable genome,nuclear hormone receptor
ESRRG	4-(1-methyl-1-phenylethyl)phenol		DrugBank	Druggable genome,nuclear hormone receptor
ESRRG	4,4'-PROPANE-2,2-DIYLDIPHENOL		DrugBank	Druggable genome,nuclear hormone receptor
ESRRG	Cholic Acid		DrugBank	Druggable genome,nuclear hormone receptor
EPHB2	VANDETANIB	inhibitor	ChemblInteractions	Druggable genome,ion channel,kinase,serine threonine kinase,transporter,tyrosine kinase
EPHB2	Phosphoaminophosphonic Acid-Adenylate Ester		DrugBank	Druggable genome,ion channel,kinase,serine threonine kinase,transporter,tyrosine kinase
TNIK	STAUROSPORINE	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase,serine threonine kinase,tumor suppressor
ADK	Adenosine monophosphate	product of	DrugBank	Druggable genome,kinase
ADK	Ribavirin	activator	DrugBank	Druggable genome,kinase
ADK	A134974	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase
ADK	ABT702	inhibitor	GuideToPharmacologyInteractions	Druggable genome,kinase
ADK	5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE		DrugBank	Druggable genome,kinase
ADK	LOMUSTINE		NCI	Druggable genome,kinase
ADK	2,3-DIDEOXYADENOSINE		NCI	Druggable genome,kinase
ADK	BLEOMYCIN		NCI	Druggable genome,kinase
ADK	7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE		DrugBank	Druggable genome,kinase
ADK	2&APOS;,3&APOS;-DIDEOXYINOSINE		NCI	Druggable genome,kinase
ADK	DACARBAZINE		NCI	Druggable genome,kinase
ADK	BUSULFAN		NCI	Druggable genome,kinase
EGLN3	DAPRODUSTAT	inhibitor	ChemblInteractions	Druggable genome,protease
EGLN3	ROXADUSTAT	inhibitor	ChemblInteractions	Druggable genome,protease
EGLN3	FG-4592		DrugBank	Druggable genome,protease
EGLN3	FG-4592		TdgClinicalTrial	Druggable genome,protease
EGLN3	FG-2216		TdgClinicalTrial	Druggable genome,protease
EGLN3	Vitamin C		DrugBank	Druggable genome,protease
KCNH3	NERISPIRDINE	blocker	ChemblInteractions	Druggable genome,ion channel,kinase,transporter
KCNH3	TEDISAMIL	blocker	ChemblInteractions	Druggable genome,ion channel,kinase,transporter
KCNH3	DALFAMPRIDINE	blocker	ChemblInteractions	Druggable genome,ion channel,kinase,transporter
KCNH3	GUANIDINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,kinase,transporter
TPCN1	PHOSPHATIDYL (3,5) INOSITOL BISPHOSPHATE	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TPCN1	CD2+	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
TPCN1	VERAPAMIL	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
FOLH1	CAPROMAB	antibody	TTD	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	Capromab		DrugBank	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	CAPROMAB	antibody	GuideToPharmacologyInteractions	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	CAPROMAB		TdgClinicalTrial	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	CAPROMAB		TEND	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	DOCETAXEL		ClearityFoundationClinicalTrial	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	DOCETAXEL	inhibitor	CancerCommons	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	CLAVULANIC ACID		TdgClinicalTrial	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	L-Glutamic Acid		DrugBank	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	MDX-070		ChemblInteractions	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	SURAMIN		NCI	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	DIHYDROTESTOSTERONE		NCI	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
FOLH1	METHOTREXATE		NCI	Cell surface,druggable genome,neutral zinc metallopeptidase,protease
GABRB3	Temazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	TEMAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	TEMAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	TEMAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	Adinazolam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	ADINAZOLAM		TEND	Druggable genome,ion channel,transporter
GABRB3	ADINAZOLAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	Piperazine	agonist	DrugBank	Druggable genome,ion channel,transporter
GABRB3	Ivermectin	agonist	DrugBank	Druggable genome,ion channel,transporter
GABRB3	Halazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	HALAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	HALAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	HALAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	PROPOFOL		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	Propofol	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	PROPOFOL		TEND	Druggable genome,ion channel,transporter
GABRB3	PROPOFOL	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	DIAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	Diazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	DIAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	DIAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	OXAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	OXAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	Oxazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	OXAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	TRIAZOLAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	Triazolam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	TRIAZOLAM		TEND	Druggable genome,ion channel,transporter
GABRB3	TRIAZOLAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	Estazolam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	ESTAZOLAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	ESTAZOLAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	ESTAZOLAM		TEND	Druggable genome,ion channel,transporter
GABRB3	ETAZOLATE	allosteric modulator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GABRB3	ETAZOLATE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	PICROTOXIN	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GABRB3	TBPS	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
GABRB3	Bromazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	BROMAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	BROMAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	Clotiazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	CLOTIAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	CLOTIAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	Fludiazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	FLUDIAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	FLUDIAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	PRAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	Prazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	PRAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	PRAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	QUAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	Quazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	QUAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	QUAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	Cinolazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	CINOLAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	CINOLAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	NITRAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	Nitrazepam	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	NITRAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	Fospropofol	potentiator	DrugBank	Druggable genome,ion channel,transporter
GABRB3	FOSPROPOFOL		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	FOSPROPOFOL		TEND	Druggable genome,ion channel,transporter
GABRB3	CHLORDIAZEPOXIDE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	CHLORDIAZEPOXIDE		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	CHLORDIAZEPOXIDE		TEND	Druggable genome,ion channel,transporter
GABRB3	CHLORDIAZEPOXIDE HYDROCHLORIDE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	ESZOPICLONE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	MEPROBAMATE	agonist	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	ALPRAZOLAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	ALPRAZOLAM		TEND	Druggable genome,ion channel,transporter
GABRB3	ALPRAZOLAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	BUTALBITAL	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	CLONAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	CLONAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	CLONAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	DESFLURANE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	TALBUTAL	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	METHARBITAL	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	MIDAZOLAM HYDROCHLORIDE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	PRIMIDONE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	PENTOBARBITAL	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	PENTOBARBITAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	SEVOFLURANE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	FLURAZEPAM HYDROCHLORIDE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	HALOTHANE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	ISOFLURANE	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	PF-06372865	agonist	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	METHOHEXITAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	METHYPRYLON	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	THIOPENTAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	CLOBAZAM		TEND	Druggable genome,ion channel,transporter
GABRB3	CLOBAZAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	CLOBAZAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	BUTABARBITAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	SECOBARBITAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	GABOXADOL	agonist	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	GABOXADOL		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	THIAMYLAL SODIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	CLORAZEPATE DIPOTASSIUM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	LORAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	LORAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	LORAZEPAM	positive allosteric modulator	ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	METHOXYFLURANE		ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	GLUTETHIMIDE		ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	MIDAZOLAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	MIDAZOLAM		TEND	Druggable genome,ion channel,transporter
GABRB3	NG2-73		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	CLORAZEPATE		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	CLORAZEPATE		TEND	Druggable genome,ion channel,transporter
GABRB3	ETOMIDATE		ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	TOPIRAMATE		ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	ETHCHLORVYNOL		ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	FLURAZEPAM		TEND	Druggable genome,ion channel,transporter
GABRB3	FLURAZEPAM		TdgClinicalTrial	Druggable genome,ion channel,transporter
GABRB3	FLUMAZENIL		ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	TRICLOFOS SODIUM		ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	ENFLURANE		ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	ACAMPROSATE CALCIUM		ChemblInteractions	Druggable genome,ion channel,transporter
GABRB3	OCINAPLON		TdgClinicalTrial	Druggable genome,ion channel,transporter
SCN8A	PHENACEMIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	HEXYLCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	ETIDOCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	PHENYTOIN	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	MEPHENYTOIN	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	MEPIVACAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	NW-3509	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	ORPHENADRINE CITRATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	VERATRIDINE	activator	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
SCN8A	SAXITOXIN	channel blocker	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
SCN8A	BC-III	gating inhibitor	GuideToPharmacologyInteractions	Druggable genome,ion channel,transporter
SCN8A	CHLOROPROCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	MEXILETINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	RILUZOLE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	QUINIDINE GLUCONATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	PRIMIDONE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	ETHOTOIN	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	DISOPYRAMIDE PHOSPHATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	DRONEDARONE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	QUINIDINE SULFATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	PRILOCAINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	PHENYTOIN SODIUM	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	TOPIRAMATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	MERETHOXYLLINE PROCAINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	PROCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	MORICIZINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	ORPHENADRINE (CHLORIDE)	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	PROPOXYCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	OXCARBAZEPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	PRILOCAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	FOSPHENYTOIN SODIUM	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	LAMOTRIGINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	LIDOCAINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	LIDOCAINE HYDROCHLORIDE HYDRATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	TOCAINIDE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	ZONISAMIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	ESLICARBAZEPINE ACETATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	NKTR-171	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	IRAMPANEL	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	NERISPIRDINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	RALFINAMIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	TETRACAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	ESLICARBAZEPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	LACOSAMIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	PROCAINAMIDE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	BENOXINATE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	ROPIVACAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	PROPARACAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	INDECAINIDE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	PHENAZOPYRIDINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	DYCLONINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	QUINIDINE POLYGALACTURONATE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	ARTICAINE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	TETRACAINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	PROPAFENONE HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	RUFINAMIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	CARBAMAZEPINE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
SCN8A	SAFINAMIDE		TdgClinicalTrial	Druggable genome,ion channel,transporter
SCN8A	TETRODOTOXIN		TdgClinicalTrial	Druggable genome,ion channel,transporter
SCN8A	Tetrodotoxin		DrugBank	Druggable genome,ion channel,transporter
F13A1	1,2-Propanediol		DrugBank	Druggable genome
CACNG7	BEPRIDIL HYDROCHLORIDE	blocker	ChemblInteractions	Druggable genome,ion channel,transporter
CACNG7	PREGABALIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNG7	GABAPENTIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNG7	GABAPENTIN ENACARBIL	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNG7	ATAGABALIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
CACNG7	IMAGABALIN	modulator	ChemblInteractions	Druggable genome,ion channel,transporter
ST14	SURAMIN		NCI	Druggable genome,protease
ST14	Urokinase		DrugBank	Druggable genome,protease
ST14	Benzamidine		DrugBank	Druggable genome,protease
GALNT14	CISPLATIN		PharmGKB	
GALNT14	FLUOROURACIL		PharmGKB	
SLC25A13	L-Aspartic Acid		DrugBank	Druggable genome,transporter
